The retained placenta

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 22, Issue 6, 2008, Pages 1103-1117

  Weeks, Andrew D ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

oxytocin; postpartum haemorrhage; retained placenta; third stage of labour

Indexed keywords

ERGOMETRINE; GLYCERYL TRINITRATE; METHYLERGOMETRINE; MISOPROSTOL; OXYTOCIN; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; SULPROSTONE;

CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFICACY; ECHOGRAPHY; HUMAN; LABOR STAGE 3; MANUAL PLACENTAL DELIVERY; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATHOPHYSIOLOGY; PLACENTA ACCRETA; PLACENTA ADHERENS; PLACENTA DISORDER; PRIORITY JOURNAL; PUERPERIUM; RETAINED PLACENTA; REVIEW; TRAPPED PLACENTA; UTERUS CONTRACTION; UTERUS DISEASE; VAGINAL DELIVERY;

FEMALE; HUMANS; LABOR STAGE, THIRD; NITROGLYCERIN; OXYTOCICS; OXYTOCIN; PLACENTA, RETAINED; PREGNANCY; UMBILICAL CORD;

EID: 54449092154     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2008.07.005     Document Type: Review

References (57)

1. Munro Kerr J.M. Maternal mortality and morbidity (1933), E & S Livingstone, Edinburgh pp 32-3
2. Confidential Enquiries into Maternal Deaths (CEMD). Why mothers die. 1997-1999 (2001), RCOG Press, London
3. Gordon J.E., Gideon H., and Wyon J.B. Midwifery practices in rural Punjab, India. Am J Obstet Gynecol 93 (1965) 734-742
4. Harrison K.A. Childbearing, health and social priorities: survey of 22,774 consecutive hospital births in Zaria, Northern Nigeria. Br J Obstet Gynaecol 92 Suppl. 5 (1985) 100-115
5. Weeks A.D., and Mirembe F.M. The retained placenta - new insights into an old problem (editorial). Eur J Obstet Gynecol Reprod Biol 102 (2002) 109-110
6. EUPHRATES Group (European Project on obstetric Haemorrhage Reduction: Attitudes, Trial and Early Warning System). European consensus on prevention and management of postpartum haemorrhage. In: B-Lynch C., Keith L.G., Lalonde A.B., and Karoshi M. (Eds). A textbook of postpartum hemorrhage (2006), Sapiens Publishing, Duncow 109-113. Available from: www.euphrates.inserm.fr
7. Hidar S., Jennane T.M., Bouguizane S., et al. The effect of placental removal method at cesarean delivery on perioperative hemorrhage: a randomized clinical trial ISRCTN 49779257. Eur J Obstet Gynecol Reprod Biol 117 2 (2004) 179-182
8. Combs C.A., and Laros R.K. Prolonged third stage of labour: morbidity and risk factors. Obstet Gynecol 77 (1991) 863-867
9. Magann E.F., Evans S., Chauhan S.P., et al. The length of the third stage of labor and the risk of postpartum hemorrhage. Obstet Gynecol 105 2 (2005) 290-293
10. Carroli G., and Bergel E. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev Issue 4 (2001) 10.1002/14651858.CD001337 Art. No.: CD001337
11. Bider D., Dulitzky M., Goldenberg M., et al. Intraumbilical vein injection of prostaglandin F2alpha in RP. Eur J Obstet Gynecol Reprod Biol 64 (1996) 59-61
12. National Collaborating Centre for Women's and Children's Health (NCCWCH). Intrapartum care. Care of healthy women and their babies during childbirth (2007), RCOG Press, London
13. WHO. Pregnancy, childbirth, postpartum and newborn care: a guide for essential practice. 2nd edn. pp B11 (2006), WHO, Geneva
14. Prendiville W.J., Elbourne D., and McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev Issue 3 (2000) 10.1002/14651858.CD000007 Art. No.: CD000007
15. Rogers J., Wood J., McCandlish R., et al. Active versus expectant management of third stage of labour: the Hinchingbrooke randomised controlled trial. Lancet 351 (1998) 693-699
16. Miller D.A., Chollet J.A., and Goodwin T.M. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 177 (1997) 210-214
17. Palcaios Jaraquemada JM. Diagnosis and management of placenta accreta. Best Pract Res Clin Obstet Gynaecol.
18. Hall M.H., Halliwell R., and Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. Br J Obstet Gynaecol 92 (1985) 732-738
19. Adelusi B., Soltan M.H., Chowdhury N., et al. Risk of retained placenta: multivariate approach. Acta Obstet Gynecol Scand 76 (1997) 414-418
20. Begley C.M. A comparison of 'active' and 'physiological' management of the third stage of labour. Midwifery 6 (1990) 3-17
21. Hammar M., Boström K., and Borgvall B. Comparison between the influence of methylergometrine and oxytocin on the incidence of retained placenta in the third stage of labour. Gynecol Obstet Invest 30 (1990) 91-93
22. Green L.K., and Harris R.E. Uterine abnormalities. Frequency of diagnosis and associated obstetric complications. Obstet Gynecol 47 (1976) 427-429
23. Golan A., Raziel A., Pansky M., et al. Manual removal of the placenta - its role in intrauterine adhesion formation. Int J Fertil Menopausal Stud 41 (1996) 450-451
24. Herman A., Weinraub Z., Bukovsky I., et al. Dynamic ultrasonographic imaging of the third stage of labor: new perspectives into third stage mechanism. Am J Obstet Gynecol 168 (1993) 1496-1499
25. Deyer T.W., Ashton-Miller J.A., Van Baren P.M., et al. Myometrial contractile strain at uteroplacental separation during parturition. Am J Obstet Gynecol 183 (2000) 156-159
26. Weeks A.D. The retained placenta. In: Studd J. (Ed). Progress in obstetrics and gynaecology vol.16 (2004), Churchill Livingston, Edinburgh
27. Weeks A.D. Placental influences on the rate of labour progression: a pilot study. Eur J Obstet Gynecol Reprod Biol 106 (2003) 158-159
28. Soltani H., Dickinson F., and Symonds I. Placental cord drainage after spontaneous vaginal delivery as part of the management of the third stage of labour. Cochrane Database Syst Rev Issue 4 (2005) 10.1002/14651858.CD004665.pub2 Art. No.: CD004665
29. Peña-Martí G., and Comunián-Carrasco G. Fundal pressure versus controlled cord traction as part of the active management of the third stage of labour. Cochrane Database Syst Rev Issue 4 (2007) 10.1002/14651858.CD005462.pub2 Art. No.: CD005462
30. Nardin J.M., Carroli G., Weeks A.D., et al. Umbilical vein injection for the routine management of third stage of labour. (Protocol). Cochrane Database Syst Rev Issue 4 (2006) 10.1002/14651858.CD006176 Art. No.: CD006176
31. Kore S., Srikristna S., Hedge A., et al. Active management of third stage of labour with intraumbilical oxytocin injection. J Obstet Gynaecol India 50 (2000) 54-55
32. Bullough C.H., Msuku R.S., and Karonde L. Early suckling and postpartum haemorrhage: controlled trial in deliveries by traditional birth attendants. Lancet 8662 (1989) 522-525
33. Gulmezoglu A.M., Villar J., Ngoc N.T., et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358 9283 (2001) 689-695
34. van Beekhuizen H.J., de Groot A.N., De Boo T., et al. Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol 194 2 (2006) 446-450
35. Pipingas A., Hofmeyr G.J., and Sesel K.R. Umbilical vessel oxytocin administration for retained placenta: in-vitro study of various infusion techniques. Am J Obstet Gynecol 168 (1993) 793-795
36. Weeks A., Mirembe F., and Alfirevic Z. The release trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta. BJOG 112 10 (2005) 1458
37. Rogers M.S., Yuen P.M., and Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand 86 1 (2007) 48-54
38. Dufour P., Vinatier D., and Puech F. The use of intravenous nitroglycerin for cervico-uterine relaxation: a review of the literature. Arch Gynecol Obstet 261 1 (1997) 1-7
39. Bullarbo M., Tjugum J., and Ekerhovd E. Sublingual nitroglycerin for management of retained placenta. Int J Gynaecol Obstet 91 3 (2005) 228-232 Erratum in: Int J Gynaecol Obstet. 2006; 92(3): 337
40. Atkinson M.W., Owen J., Wren A., et al. The effect of manual removal of the placenta on post-cesarean endometritis. Obstet Gynecol 87 (1996) 99-102
41. Ely J.W., Rijhsinghani A., Bowdler N.C., et al. The association between manual removal of the placenta and postpartum endometritis following vaginal delivery. Obstet Gynecol 86 (1995) 1002-1006
42. Chhabra S., and Dhorey M. Retained placenta continues to be fatal but frequency can be reduced. J Obstet Gynaecol 22 6 (2002) 630-633
43. Onwudiegwu U., and Makinde O.N. Retained placenta: a cause of reproductive morbidity in Nigeria. J Obstet Gynaecol 19 4 (1999) 355-359
44. Harrison K.A. Mode of delivery with notes on rupture of the gravid uterus and vesicovaginal fistula. Br J Obstet Gynaecol 92 Suppl. 5 (1985) 61-71
45. Sheiner E., Levy A., and Mazor M. Precipitate labor: higher rates of maternal complications. Eur J Obstet Gynecol Reprod Biol 116 1 (2004) 43-47
46. Dombrowski M.P., Bottoms S.F., Saleh A.A., et al. Third stage of labor: analysis of duration and clinical practice. Am J Obstet Gynecol 172 (1995) 1279-1284
47. Titiz H., Wallace A., and Voaklander D.C. Manual removal of the placenta-a case control study. Aust N Z J Obstet Gynaecol 41 1 (2001) 41-44
48. Zhou W., Nielsen G.L., Larsen H., et al. Induced abortion and placenta complications in the subsequent pregnancy. Acta Obstet Gynecol Scand 80 (2001) 1115-1120
49. Calderdale L., Dalle N.F., Franzoi R., et al. Éutile la somministrazione di ossitocina nella vena ombilicale per il trttamento della placenta ritenuta?. G Ital Ostet Ginecol 16 5 (1994) 283-286 Quoted in: Carroli G, Bergel E. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev 2001, Issue 4. Art. No.: CD001337. DOI: 10.1002/14651858.CD001337
50. Hansen P., Jorgensen L., Dueholm M., et al. Intraumbilical oxytocin in the treatment of retained placenta. Ugeskr Laeger 149 (1987) 3318-3319 Quoted in: Carroli G, Bergel E. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev 2001, Issue 4. Art. No.: CD001337. DOI: 10.1002/14651858.CD001337
51. Frappell J.M., Pearce J.M., and McParland P. Intra-umbilical vein oxytocin in the management of retained placenta: a random, prospective, double blind, placebo controlled study. J Obstet Gynaecol 8 (1988) 322-324
52. Huber M.G.P., Wildschut H.I.J., Boer K., et al. Umbilical vein administration of oxytocin for the mangement of retained placenta: it is effective?. Am J Obstet Gynecol 164 (1991) 1216-1219
53. Selinger M., Mackenzie I.Z., Dunlop P., et al. Intra-umbilical vein oxytocin in the management of retained placenta. A double blind placebo controlled study. J Obstet Gynaecol 7 (1986) 115-117
54. Kristiansen F.V., Frost L., Kaspersen P., et al. The effect of oxytocin injection into the umbilical vein for the management of retained placenta. Am J Obstet Gynecol 156 (1987) 979-980
55. Gazvani M.R., Luckas M.J.M., Drakeley A.J., et al. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial. Obstet Gynecol 91 (1998) 203-207
56. Carroli G., Belizan J.M., Grant A., et al. For the Grupo Argentino de Estudio de Placenta Retenida. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Br J Obstet Gynaecol 105 (1998) 179-185
57. Wilken-Jensen C., Strom V., Nielsen M.D., et al. Removing placenta by oxytocin - a controlled study. Am J Obstet Gynecol 161 (1989) 155-156